Self-reports of anxiety in burn-injured hospitalized adults during routine wound care.
The purpose of this investigation was to examine the amount of anxiety patients believed tolerable and the amount of anxiety experienced during routine burn wound care. Participants included 47 hospitalized adults who provided data for four consecutive assessment periods. Patients (mean TBSA, 16%; range, 2-70%) were primarily Caucasian (87%) and had an average hospital stays of 23 days (range, 11-130). Reports of what level of anxiety they would be able to tolerate and what level of anxiety had been experienced were assessed using 10-point Graphic Rating Scales. The use of anxiolytic was recorded, and patient suggestions for reducing anxiety were obtained. The single most commonly endorsed anxiety treatment goal was 0, although 53% consistently chose a treatment goal other than 0 (range, 1-6). Two repeated-measure analyses of variance indicated that the amount of anxiety patients could tolerate and the amount they reported experiencing did not change over the course of time. Paired t-tests revealed that patients routinely reported more anxiety than they considered tolerable. Analyses of anxiety reports of patients treated with anxiolytics (n = 6) vs patients receiving no anxiolytics (n = 41) revealed inconsistent differences in actual anxiety and treatment goals across time. In general, patient suggestions for lessening anxiety included requests for education, communication, additional medications, and manipulation of the hospital environment. Anxiety for burn-injured, hospitalized adults remains a concern. Our findings are consistent with the literature indicating that adult patients hospitalized for burn wound care report appreciable anxiety, over and above what they consider "tolerable." Continued research is needed and should include investigations into the relationship between pain and anxiety during routine wound care.
Carrougher
Gretchen J
GJ
Department of Surgery, University of Washington, Seattle, Washington, USA.
Ptacek
J T
JT
Honari
Shari
S
Schmidt
Anne E
AE
Tininenko
Jennifer R
JR
Gibran
Nicole S
NS
Patterson
David R
DR
D000293:Adolescent; D000328:Adult; D000368:Aged; D000704:Analysis of Variance; D014151:Anti-Anxiety Agents / Q000627:therapeutic use; D001007:Anxiety / Q000453:epidemiology* / Q000628:therapy; D001458:Bandages; D002056:Burns / Q000453:epidemiology / Q000523:psychology* / Q000628:therapy; D003142:Communication; D003646:Debridement; D005260:Female; D006760:Hospitalization; D006801:Humans; D006875:Hydrotherapy; D008140:Lorazepam / Q000627:therapeutic use; D008297:Male; D008875:Middle Aged; D020380:Needs Assessment; D010353:Patient Education as Topic; D011446:Prospective Studies; D011569:Psychiatric Status Rating Scales; D014861:Washington / Q000453:epidemiology
D014151:Anti-Anxiety Agents; D008140:Lorazepam